MassMutual Private Wealth & Trust’s Avidity Biosciences RNAM Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$72	–	2475
2025 Q4	$72	Buy	+1	New	+$65	﹤0.01%	2348
2025 Q2	–	Sell	-27	Closed	-$797	–	2477
2025 Q1	$797	Sell	27 -27	-50%	-$841	﹤0.01%	2174
2024 Q4	$1.57K	Buy	+54	New	+$2.26K	﹤0.01%	1897
2021 Q2	–	Sell	-17	Closed	–	–	1280
2021 Q1	$0	Buy	+17	New	+$416	﹤0.01%	1168

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

MassMutual Private Wealth & Trust's RNAM Position: Q1 2026 in Review

MassMutual Private Wealth & Trust sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1 share — an estimated $72 sold.

MassMutual Private Wealth & Trust first reported a position in RNAM in Q1 2021 and held it in 4 quarters. The position peaked at $1.57K in Q4 2024. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

MassMutual Private Wealth & Trust reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 1 Avidity Biosciences share in Q1 2026, an estimated $72.
MassMutual Private Wealth & Trust first reported a position in Avidity Biosciences in Q1 2021 and held it in 4 quarters.
MassMutual Private Wealth & Trust's Avidity Biosciences position peaked at $1.57K in Q4 2024.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2026, filed 13 Apr 2026.